small molecule

SEZABY

PHENOBARBITAL SODIUM

Loss of exclusivityApril 2042latest FDA-listed patent expiry

CompanySUN PHARMACEUTICAL INDUSTRIES INC

Drug detail

Brand name	SEZABY
Active ingredient	PHENOBARBITAL SODIUM
Strength	100MG/VIAL
Dosage form	POWDER
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	November 2022
Marketing status	RX

Listed patents

Patent	Expires	Type
11857683	April 2042	product
12636254	April 2042	product

Regulatory exclusivity

Code	Expires
ODE-414	November 2029

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from SUN PHARMACEUTICAL INDUSTRIES INC